Perspectives on Enquiry & Evidence

Cytel's blog featuring the latest industry insights.

Reflections on the RCT DUPLICATE Study and Increasing Confidence in Real-World Evidence

Randomized clinical trials (RCTs) have long been considered the gold standard for assessing the efficacy of medical treatments, but real-world evidence (RWE) is often more representative of routine clinical care. The RCT DUPLICATE study makes great strides in comparing the two, but the study has its limitations: notably, the lack of quantitative bias analysis.

Read full article

luke-southern-9yCYGgPe5Kg-unsplash_1104

Clear Filters

Filter by

Topic

Author

May 24, 2022

Leveraging Advanced Statistical Software to Optimize Clinical Development

Traditionally, clinical trials are expensive, long in duration, and have low success rate. But with the advent of rich..

Read article

May 12, 2022

Estimator Choice in Synthetic Control Arm Analyses

Synthetic control arm (SCA) methods are statistical methods that are seeing rapidly increasing use in comparative..

Read article

May 5, 2022

Interview with Grammati Sarri on Moderating an Issue Panel 2022

While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..

Read article

May 4, 2022

Optimizing Human-Machine Partnership for Up-To-Date Evidence

If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a..

Read article

April 29, 2022

An Interview with Gabriel Tremblay on his Poster Contributions to ISPOR US 2022

At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium..

Read article

April 21, 2022

Bayesian Statistics and Its Applications: New Webinar by Professor Yuan Ji

Sophisticated Bayesian Methods are gaining a lot of traction as they bring flexibility and speed to clinical trial..

Read article

April 13, 2022

Join Cytel’s HEOR Consultants at ISPOR US 2022

The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated..

Read article

April 12, 2022

Career Perspectives: Interview with Charles Warne, Associate Director of Biostatistics

In this edition of the Career Perspectives series, I interview Charles Warne, Associate Director of Biostatistics at..

Read article

February 9, 2022

How can an optimized data strategy support your clinical program?

Data is the cornerstone of any clinical trial and is used to ultimately drive the decision-making process related to..

Read article

Previous |All posts| Next